Buy EYLEA Aflibercept 40mg/1ml Bayer Online For Sale

Description

EYLEA (Aflibercept) is a medication used to treat various eye conditions, such as wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion. It is a recombinant fusion protein that binds to vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), reducing the growth of abnormal blood vessels and inflammation, and improving vision in patients with these conditions.

Uses:

EYLEA is used to treat macular edema following retinal vein occlusion, diabetic macular edema, wet age-related macular degeneration, and macular edema following diabetic retinopathy. It is typically administered as an injection into the eye by a healthcare professional.

Storage Conditions:

EYLEA should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F). The medication can be stored at room temperature (up to 25°C or 77°F) for up to 24 hours before use. Do not freeze or shake EYLEA. Protect it from light and do not use it if it becomes discolored or has particles.

Mechanism of Action:

EYLEA works by binding to and disabling VEGF and PlGF, which are proteins that promote the growth of new blood vessels. This action prevents the abnormal growth of blood vessels in the retina, reduces leakage, and decreases inflammation, all of which contribute to vision loss.

HOW TO USE:

EYLEA is administered as an injection into the eye by a healthcare professional. The injection is typically given once a month but may be given less frequently in some patients. Prior to the injection, the eye is numbed with a local anesthetic, and the injection is performed in a sterile environment. Patients should inform their healthcare provider of any allergies or other medical conditions that they have before undergoing treatment with EYLEA.

Precautions:

Patients with a history of allergies to any of the ingredients in EYLEA or other medications should inform their healthcare provider before treatment. Patients should also inform their provider of any eye conditions, such as infections or inflammation, prior to receiving treatment. EYLEA may cause certain eye problems, such as increased pressure in the eye, which may require further treatment. EYLEA may also increase the risk of blood clots, heart attacks, and strokes in some patients. Patients should be monitored for signs of these conditions during treatment.

Drug Interactions:

There are no known drug interactions with EYLEA. However, it is important to inform healthcare providers of all medications being taken, including over-the-counter and herbal products, prior to starting treatment.

Contraindications:

EYLEA is contraindicated in patients with a history of allergies to any of the ingredients in the medication or to other similar medications. It should also not be used in patients with active or suspected infections in or around the eye.

Overdose:

There is no known antidote for an EYLEA overdose. Patients who may have received too much of the medication should be monitored closely for adverse reactions, which may require further treatment.

Adverse Reactions:

The most common adverse reactions associated with EYLEA include eye pain, floaters, conjunctival hemorrhage, and increased eye pressure. More severe reactions may occur, such as retinal detachment, endophthalmitis, and blindness. Patients should report any adverse reactions to their healthcare provider immediately.

In conclusion, EYLEA is an effective medication for the treatment of various eye conditions. It is typically administered by a healthcare professional as an injection into the eye and works by reducing the growth of abnormal blood vessels and inflammation, improving vision in patients with these conditions. Patients should inform their healthcare provider of any allergies or other medical conditions that they have before undergoing treatment with EYLEA. EYLEA may cause certain eye problems and increase the risk of blood clots, heart attacks, and strokes in some patients. Patients should be monitored for signs of adverse reactions during treatment.